title: Studies with purified human thyroid peroxidase and thyroid microsomal autoantibodies.
abstract: We have isolated highly purified thyroid peroxidase (TPO) from human thyroid tissue to study further the relationship between TPO and the thyroid microsomal antigen that elicits the production of microsomal autoantibodies in patients with autoimmune thyroid disease. Serum samples were obtained from 24 patients with suspected autoimmune thyroid disease, and from 7 normal subjects. Microsomal autoantibodies in the patient sera, as determined by the microsomal hemagglutination assay (MCHA), varied between 1:100 and 1:102,400. Antithyroglobulin antibodies, however, were very low (less than 1:100). Binding of serum autoantibodies to purified human TPO, as determined by enzyme-linked immunosorbent assay, correlated fairly well with MCHA titers (r = 0.72; P less than 0.001). An immunoblot procedure was developed to study the binding of serum antibodies to the major active fragment of TPO (93 kDa), after sodium dodecyl sulfate-polyacrylamide gel electrophoresis under both reducing and nonreducing conditions. Binding under both conditions correlated very well with MCHA titers (r = 0.80-0.84; P less than 0.001). Studies were performed to determine the inhibitory effect of patient serum on the enzymatic activity of purified human TPO. A marked inhibitory effect on guaiacol activity was observed when TPO was preincubated with as little as 10 microL high titer serum. There was a significant correlation (r = 0.47; P less than 0.01) between MCHA titer and inhibitory effect. The addition of 2 micrograms purified human TPO completely or almost completely inhibited the binding of serum antibodies to thyroid microsomes (enzyme-linked immunosorbent assay) in 10 of 11 patient sera with high MCHA titers (1:25,600 or greater).
authors.affiliation: Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75235.
authors.forename: N
authors.initials: N
authors.lastname: Yokoyama
authors.forename: A
authors.initials: A
authors.lastname: Taurog
authors.forename: M L
authors.initials: ML
authors.lastname: Dorris
authors.forename: G G
authors.initials: GG
authors.lastname: Klee
mesh_terms: D000917:Antibody Formation; D001323:Autoantibodies / Q000276:immunology* / Q000494:pharmacology; D001324:Autoantigens / Q000276:immunology* / Q000302:isolation & purification; D001666:Binding Sites, Antibody / Q000187:drug effects; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D015151:Immunoblotting; D007074:Immunoglobulin G / Q000276:immunology; D007453:Iodide Peroxidase / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000302:isolation & purification; D033862:Iron-Binding Proteins; D008297:Male; D008875:Middle Aged; D013961:Thyroid Gland / Q000201:enzymology* / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000276:immunology
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D007074:Immunoglobulin G; D033862:Iron-Binding Proteins; C056626:thyroid microsomal antibodies; C056658:TPO protein, human; D007453:Iodide Peroxidase